NEPTUNE, N.J.--(BUSINESS WIRE)--Excelsior Medical Corporation announced today that it has received FDA 510(k) clearance for SwabFlush™, its latest product for the vascular access and infection control ...

In advanced clinical practice, up to 4/5th of the hospitalized patients require intravenous therapy at some point during their hospital stay. This intravenous route can involve administering ...

To determine the efficacy of heparinized saline administered as intermittent flush on functional duration of the peripheral intravenous catheter (PIVC) in neonates. A total of 120 neonates were ...

Heparin is routinely used to keep central venous catheters patent but is it the most effective flush solution? A systematic review was undertaken to find out AbstractAnderson BJ et al (2010) What is ...

NORTHFIELD, Ill.--(BUSINESS WIRE)--According to the CDC, considerable progress is being made in preventing central line associated blood stream infections, but further improvement is still needed. An ...

Early results of a prospective, peer-reviewed clinical trial demonstrated SwabCap® improved disinfection and allowed for reduced central line-associated bloodstream infection (CLABSI) rates by more ...

Stage-Specific Outcomes of Patients With Uterine Leiomyosarcoma: A Comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems During ...

The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult ...

OBJECTIVES: The optimal method for epinephrine administration during neonatal resuscitation is not known. We hypothesized that epinephrine will be delivered more efficiently when administered via a ...

SwabFlush combines SwabCap and the ZR Catheter Flush Syringe into one device, to make it easier for nurses to flush, disinfect and protect the IV connector all at the same time. (Photo: Business Wire) ...